Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma

Name: Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
License: Public Domain

Northwestern University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diffuse large b-cell lymphoma associated with chronic inflammation, ebv-positive diffuse large b-cell lymphoma, not otherwise specified, high grade b-cell lymphoma, not otherwise specified, large b-cell lymphoma with irf4 rearrangement, primary cutaneous diffuse large b-cell lymphoma, leg type, recurrent aggressive b-cell non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 154648
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.